Journal
BONE MARROW TRANSPLANTATION
Volume 29, Issue 6, Pages 523-525Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bmt.1703398
Keywords
follicular lymphoma; radioimmunotherapy; iodine I-131-tositumomab; autologous PBSCT
Categories
Ask authors/readers for more resources
While the use of radioimmunotherapy for lymphoma increases, the feasibility and efficacy of autologous stem cell transplant for subsequent relapse remains unknown. We report a 48-year-old male with transformed follicular mixed non-Hodgkin's lymphoma. After treatment with three different combination chemotherapy regimens, at relapse he received radioimmunotherapy with iodine I-131 tositumomab (anti-CD20), with very good response. At later relapse, a second course of I-131 tositumomab was given unsuccessfully. He underwent peripheral blood stem cell harvest, chemoradiotherapy conditioning and autologous transplantation with prompt engraftment and without significant complications. He remains in complete remission with normal blood counts 25 months post autograft.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available